CMS releases a new rule for hospitals, healthcare organizations criticize the decision, the rule goes into effect anyway, and the cycle continues. Peter Pronovost, MD, PhD, wants to see this story be rewritten.
Two drug companies will pay a combined $49.1 million for their alleged involvement in schemes to inflate drug prices and limit competition in the generic pharmaceuticals market nationwide, the Connecticut Law Tribune reported Oct. 31.
Chris Woleske, who has held leadership roles with Bellin Health and Bellin and Gundersen Health System for more than 26 years, is retiring as executive vice president and Bellin Region president.
New Jersey Attorney General Matthew Platkin has permanently revoked the license of a cardiologist who owned and operated Matawan-Aberdeen Heart & Medical Center in Matawan, N.J., following his conviction in a $1.9 million fraud scheme.
In the last month, five lawsuits have emerged with significant implications for the ASC industry, covering critical issues from fraud and reimbursement disputes to rising nuclear verdicts and malpractice settlements.